Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novartis, Sandoz In Tangle With Trade Channels Over Direct Drug Sales In India

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - A five year-long dispute over drug sales with India's largest trade body - the Pharmaceutical Wholesalers Association - has returned to hound Novartis. The powerful trade association has boycotted all products of Novartis and its generic drugs arm Sandoz in Mumbai, alleging that the two companies have been selling some high-value drugs directly to patients, thereby violating agreements over trade margins and also circumventing laws governing price control of drugs in India

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts